Orakl Oncology
FranceEntry
2024
Hold
2yr
Status
Active
Who owns Orakl Oncology?
Orakl Oncology is a French HealthTech company, currently owned by Singular Capital Partners since 2024 and SISTAFUND.
Hand-verified · updated 2026-04-21
Open JSON · CC-BY
Most recent investor
Singular Capital PartnersSingular Ventures II · 2023 · VC
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2023 · present
SISTAFUNDActive
2023 · present(3yr) · SISTA Fund I · 2022 · VC
More from Singular Ventures II
Other portfolio companies in the same fund.
UK
GermanyMore PE-backed in HealthTech
Comparable healthtech deals from other GPs.
US
Questions
Who owns Orakl Oncology?
Orakl Oncology is currently owned by Singular Capital Partners and SISTAFUND, through Singular Ventures II, since 2024.
When did Singular Capital Partners and 1 other acquire Orakl Oncology?
Singular Capital Partners and 1 other acquired Orakl Oncology in 2024.
Who has owned Orakl Oncology over time?
Orakl Oncology has been through 2 private-equity ownership periods: SISTAFUND · via SISTA Fund I · since 2023; Singular Capital Partners · via Singular Ventures II · since 2024.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue